Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
Global Key SolutionsGKS
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. ACTA Laboratories, Inc.
483
•ACTA Laboratories, Inc.•February 13, 2023

FDA 483 - ACTA Laboratories, Inc. - February 13, 2023

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

ACTA Laboratories, Inc. in Foothill Ranch, CA, was inspected and received a Form 483 with three observations. The inspection revealed significant issues with the quality control unit's procedures, including failures in stability program investigations, sample processing, and lack of written procedures for critical activities. Additionally, deficiencies were noted in ongoing GMP training for employees and adherence to written sanitation procedures, with evidence of pest activity.

Company
ACTA Laboratories, Inc.
Inspection Date
February 13, 2023
Product Type
Drugs
Office
Division of Pharmaceutical Quality Operations IV
People
  • Andrew Le (Regulatory Affairs Specialist)
  • Claudia M. Perez-Kasmarski
Open in Dashboard

ID · fd8b0370-6612-4fb9-b6b4-609d11fb0cf2

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
KeyPedia™ Lite
Legal & Ethics
©2026, Global Key Solutions All rights reserved.